Refractory Neuroblastoma Active Not Recruiting Phase 2 Trials for Tazemetostat (DB12887)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0047201 (Refractory Neuroblastoma) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03213665 | Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) | Treatment |